Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

BACKGROUND: Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be mutated, amplified, or overexpressed in different malignancies, including non-small cell lung cancer (NSCLC). Although these alterations showed adverse prognostic effects in many cancers, their clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Al Karsaneh, Ola, Al Anber, Arwa, ALQudah, Mohammad, Al-Mustafa, Sahar, AlMa’aitah, Hussien, Sughayer, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283286/
https://www.ncbi.nlm.nih.gov/pubmed/37340403
http://dx.doi.org/10.1186/s13000-023-01364-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283286/
https://www.ncbi.nlm.nih.gov/pubmed/37340403
http://dx.doi.org/10.1186/s13000-023-01364-2

Ejemplares similares